(Q33748875)

29 July 2017

1 reference

title

Discriminative stimulus properties of antipsychotics (English)

1 reference

29 July 2017

Goudie AJ

1

1 reference

29 July 2017

Smith JA

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Pharmacology, Biochemistry and Behavior

29 July 2017

published in

1 reference

29 July 2017

volume

64

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

193-201

1 reference

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Inhibitory effects on the discriminative stimulus properties of D-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Pharmacological actions of the atypical antipsychotic drug clozapine: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Cyproheptadine in movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

D1 receptor antagonists in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907: role of presynaptic dopamine D2 autoreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity: a review of its behavioural properties

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Discriminative-stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Theoretical and methodological considerations on drug discrimination learning

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Discriminative stimulus properties of the dopamine D3 antagonist PNU-99194A.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

The discriminative stimulus properties of an ethanol-nicotine mixture in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Discriminative stimulus properties of clozapine and chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Clozapine: back to the future for schizophrenia research

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Mechanisms of action of atypical antipsychotic drugs: a critical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Dopamine D2 receptors play a role in the (-)-apomorphine-like discriminative stimulus effects of (+)-PD 128907.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Discriminative stimulus properties of 7-OH-DPAT, a dopamine D3-selective receptor ligand.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Cholinergic mediation of the discriminative stimulus properties of clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Cueing effects of amphetamine and LSD: elicitation by direct microinjection of the drugs into the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Discriminative stimulus control with olanzapine: generalization to the atypical antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

What is an atypical antipsychotic?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Discriminative stimulus effects of apomorphine and 7-OH-DPAT: a potential role for dopamine D3 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

A functional test identifies dopamine agonists selective for D3 versus D2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

The D3 dopamine receptor in cellular and organismal function

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Treatment of chronic schizophrenia with cyproheptadine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Novel dopamine receptors half a decade later

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Schizophrenia and glutamatergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Investigations into the nature of a 7-OH-DPAT discriminative cue: comparison with D-amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900079-9

7 January 2021

10.1016/S0091-3057(99)00079-9

Identifiers

DOI

1 reference

release_fzkgkbhxjzachb5v7woq6cetvq

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fzkgkbhxjzachb5v7woq6cetvq

24 November 2022

mapped directly with Wikidata item

1 reference